| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 23 Oct 2025 | 23 Oct 2025 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held on 23rd October, 2025, has approved the appointment of Ms. Sridevi Belide (DIN: 10455373) as an Additional Director (Non Executive Non-Independent) of the Company with effect from 23rd October, 2025 | ||
| Board Meeting | 14 Aug 2025 | 7 Aug 2025 |
| Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Submission of Prior Intimation of Board Meeting to be held on Thursday 14th August 2025 to transaction the business mentioned in the file attached herewith. (As Per BSE Announcement Dated on: 14/08/2025 Submission of intimation of allotment of equity shares upon conversion of warrants. (As Per BSE Announcement Dated on: 15/08/2025) | ||
| Board Meeting | 24 Jun 2025 | 21 Jun 2025 |
| Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/06/2025 inter alia to consider and approve Submission of Prior Intimation of Board Meeting to be held on Tuesday 24th June 2025 1. To consider and approve the conversion of Warrants into Equity Shares of the Company. 2. Any other matter with the permission of chair. Submission of outcome of board meeting held on Tuesday, 24th June, 2025 (As Per BSE Announcement dated on 24.06.2025) | ||
| Board Meeting | 27 May 2025 | 20 May 2025 |
| Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve To Consider and Approve the audited standalone financial results for the quarter and year ended March 31 2025 along with limited review report of the auditors and other items. Submission of intimation of appointment of secretarial auditor of the company. (As Per BSE Announcement dated on 27.05.2025) | ||
| Board Meeting | 12 Apr 2025 | 9 Apr 2025 |
| Inter alia, to consider and approve:- 1. To consider and approve the convening of an EGM for seeking shareholder approval for the confirmation of appointment of Mr. Laxman Samala as Non-Executive Independent Director of the Company. 2. To appoint a scrutinizer for to scrutinize the voting process for the upcoming EGM. 3. Any other item with the approval of the chairman. Submission of outcome of Board Meeting held on 12th April, 2025 (As Per Bse Announcement Dated on 12.04.2025) | ||
| Board Meeting | 12 Feb 2025 | 6 Feb 2025 |
| Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, intimation is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th February 2025 at 05:00 P.M. at the Registered office of the Company, inter-alia to discuss the following: 1. To consider, approve and take on record the unaudited Financial Results of the company for the quarter ended 31st December 2024. 2. To consider and take note of Limited Review Report for the quarter ended 31st December 2024. 3. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter ended 31st December 2024. 4. Any other item with the approval of the chairman. Appointment of Mr. Lakshman Samala as Independent Director and Ms. Bhoomika Choudhary Chief Financial officer. (As Per BSE Announcement dated on 12.02.2025) | ||
| Board Meeting | 13 Nov 2024 | 9 Nov 2024 |
| Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 intimation is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday 13th November 2024 at 05.00 P.M at the Registered office of the Company inter-alia to discuss the following: 1. To consider approve and take on record the un-audited Financial Results of the company for the quarter and half year ended 30th September 2024. 2. To consider and take note of Limited Review Report for the quarter and half year ended 30th September 2024. 3. To take note of the Certificate of Whole Time Director & Chief Financial Officer of the Company for the quarter and half year ended 30th September 2024. 4. To consider and approve the appointment of the Director of the Company. 5. Any other item with the approval of the chairman. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 13th November 2024, at 05:00 PM and concluded at 10:30 PM, at the registered office of the Company inter-alia considered and approved the following: 1. Considered, reviewed and approved the Un-audited Financial Statements for the Quarter and half yearly Ended 30th September 2024. 2. Considered, reviewed and taken note of the Limited Review Report on the un-audited financial statements of the Company for quarter and half yearly ended 30th September 2024. 3. Taken note of the Compliance Certificate submitted in compliance with SEBI (LODR), 2015. 4. Reviewed and approved the related party transactions for the Quarter and half yearly Ended 30th September 2024. The said meeting commenced at 05:00 p.m. and concluded at 10:30 p.m. (As per BSE Announcement Dated on 13/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.